CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /UPM Pharmaceuticals
    UPM Pharmaceuticals logo

    UPM Pharmaceuticals

    Founding PartnerVerified
    CDMO
    United States
    http://www.upm-inc.com
    Drug Product
    Analytical & Bioanalytical Services
    Regulatory, Tech Transfer & Support Services
    Chemistry, Manufacturing and Controls
    Clinical Trial Supply & Logistics
    Qualification/Validation Services
    Company Overview

    About

    UPM Pharmaceuticals is a U.S.-based CDMO specializing in late-stage commercial manufacturing of oral solid dose products. Operating from a 450,000 sq.ft. cGMP FDA-registered facility in Bristol, Tennessee, UPM is a family-owned company with 25+ years of experience. They handle DEA-controlled substances and provide services from technology transfer and scale-up through commercial manufacturing. Capabilities include formulation development, analytical development, coated tablet manufacturing, pharmaceutical serialization, aggregation, and full packaging and warehousing.

    Key Expertise

    oral solid dosage commercial manufacturing, DEA-controlled substances handling, technology transfer and scale-up, pharmaceutical serialization, coated tablets

    Project Experience

    85+ completed projects

    Therapeutic Areas

    Oncology
    Infectious Disease
    Cardiovascular
    CNS (Central Nervous System)
    Metabolic Disease
    Rare Disease
    Quick Facts
    HQ:United States
    Capabilities & Services

    Core Capabilities

    • Small Molecule Drug Product
    • Oral Solid Dose
    • Formulation Development
    • Analytical Services
    • Method Development & Validation
    • Stability Studies
    • Regulatory Support
    • Packaging & Labeling
    • Process Development
    • Quality Control
    • Scale-up
    • Solid Dose Manufacturing
    • Topicals
    • Microbiology Testing

    Types of Organization

    Analytical & Bioanalytical Laboratory
    Clinical Trial Supply & Logistics Provider
    Commercial Manufacturing
    Drug Product Manufacturer (finished dosage, fill-finish, packaging)
    Formulation Development

    Dosage Forms

    Oral Solid Dose

    Containment Capabilities

    DEA Schedule II-V

    Production Scales

    Clinical
    Phase III Clinical Trials
    Commercial Scale
    Large Scale (Metric Ton+)
    R&D / Pre-clinical
    Phase I Clinical Trials
    Phase II Clinical Trials
    Pilot Scale

    Batch Sizes

    < 1L
    1L - 10L
    10L - 100L
    100L - 1,000L

    Annual Capacity

    Commercial (1,000 - 10,000 kg/year)
    Large Commercial (> 10,000 kg/year)

    Markets Served

    North America
    Latin America
    Asia Pacific
    Manufacturing Facilities

    1 site worldwide

    UPM Pharmaceuticals - United States Facility

    United States
    View on Map

    Site Capabilities

    3 capabilities
    Gene Therapy
    Cell Therapy
    mRNA
    Certifications

    FDA Registration

    U.S. Food and Drug Administration

    GMP (Good Manufacturing Practice)

    Various National Authorities

    FDA (U.S. Food & Drug Administration)

    Various

    ICH (International Council for Harmonisation)

    International Council for Harmonisation

    DEA (Drug Enforcement Administration)

    U.S. Drug Enforcement Administration

    PMDA (Japan Pharmaceuticals and Medical Devices Agency)

    Pharmaceuticals and Medical Devices Agency

    Health Canada

    Various
    Send Inquiry

    Please log in to contact this provider.

    Key facts about UPM Pharmaceuticals

    • UPM Pharmaceuticals is headquartered in the United States.
    • UPM Pharmaceuticals has one manufacturing site listed on CDMO Hub, in the United States.
    • UPM Pharmaceuticals's capabilities include Small Molecule Drug Product, Oral Solid Dose, Formulation Development, Analytical Services, Method Development & Validation, Stability Studies, Regulatory Support and Packaging & Labeling.

    Specialty pages

    Dedicated, in-depth pages for UPM Pharmaceuticals’s core service areas.

    Oral Solid Dose ManufacturingUPM Pharmaceuticals provides end-to-end development and manufacturing for oral solid dosage forms — tablets and capsules — from early clinical batches through full commercial supply. As an independent US CDMO operating a cGMP facility in Bristol, Tennessee, UPM supports immediate-release and modified-release products, process optimization, packaging, and ongoing product lifecycle management under one roof.View specialty →Technology Transfer & Scale-UpTechnology transfer is one of UPM Pharmaceuticals’ core areas of expertise. UPM works with pharmaceutical innovators, virtual biotech companies, and development-stage organizations seeking a manufacturing partner to carry a product from development environments into later-stage clinical and commercial production — reducing execution risk and accelerating time to market.View specialty →

    Find CDMOs like UPM Pharmaceuticals

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in United StatesCDMOs in North AmericaSmall Molecule Drug Product CDMOsOral Solid Dose CDMOsFormulation Development CDMOsAnalytical Services CDMOsMethod Development & Validation CDMOsStability Studies CDMOsRegulatory Support CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA